spacer
home > subscribe
SUBSCRIPTION FORM

Our magazines are available free of charge on a controlled basis to senior level management within the pharmaceutical industry. Click on the following links for the relevant subscription form. Alternatively, if you do not qualify for a free subscription, please complete the below.

European Biopharmaceutical Review

European Pharmaceutical Contractor 

International Clinical Trials 

Innovations in Pharmaceutical Technology 

Pharmaceutical Manufacturing and Packing Sourcer

If you do not meet our qualification criteria, please fill in the form below for a paid subscription. The annual subscription price for one title is £145. 

Cheques should be made payable to Samedan Ltd, First Floor, 131 Edgware Road, London, W2 2HR, UK. Credit card details can be given over the telephone - please ask for the Accounts Department. Back issues of the publications are available. For further details, please contact our Circulation Department on +44 (0)20 7724 3456.

Title: First Name: Last Name:
Address 1:
Address 2:
Town / City: ZIP / Post Code:
Country: Other:
Tel.: E-mail:
Subscribe to:IPTICTPMPSEBR
Additional Information:
Payment Method:
online   cheque/postal ordrer  
spacer
News and Press Releases

IMFINZITM (durvalumab) WITH CHEMOTHERAPY DEMONSTRATED A SUSTAINED OVERALL SURVIVAL BENEFIT IN 1ST-LINE EXTENSIVE-STAGE SMALL CELL LUNG CANCER IN THE PHASE III CASPIAN TRIAL

Detailed results from an updated analysis of the Phase III CASPIAN trial showed AstraZeneca’s Imfinzi (durvalumab) in combination with a choice of chemotherapies, etoposide plus either carboplatin or cisplatin, demonstrated a sustained, clinically meaningful overall survival (OS) benefit for adults with extensive-stage small cell lung cancer (ES-SCLC) treated in the 1st-line setting.
More info >>

.
White Papers
 
Industry Events

Evolution Summit

20-22 July 2020, The Ritz Carlton, Fort Lauderdale, FL

The 22nd Evolution Summit is the premium forum bringing leading drug development executives and solution providers together. As an invitation-only event, taking place behind closed doors, the Summit offers an intimate environment for a focused discussion of key new drivers shaping drug development.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement